Metrizoic acid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Metrizoic acid
DrugBank Accession Number
DB09346
Background

Metrizoic acid is a molecule used as a contrast medium. It present a higher risk of allergic reactions due to its high osmolality. Its approval has been discontinued by the FDA. One study in 1976 demonstrated that metrizoic acid, when used for cardiac angiography, was well tolerated. A total of 10, 000 injections were administered to 2,028 patients undergoing angiocardiographic procedures over a three-year period. With two exceptions, all complications occurred during injection of the right coronary artery. Seven cases of ventricular fibrillation, and 5 of significant bradycardia/asystole, were associated with metrizoic acid injection. In general, the drug was well tolerated by patients during cardiac examinations 1.

Type
Small Molecule
Groups
Approved
Structure
Weight
Average: 627.943
Monoisotopic: 627.78529
Chemical Formula
C12H11I3N2O4
Synonyms
  • Metrizoic acid
External IDs
  • V08AA02

Pharmacology

Indication

For use as a contrast medium 2.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action

The mechanism of action of metrizoic acid is as an X-Ray contrast activity 2.

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Calcium metrizoate1I3Z5LHR6P20828-80-2PPUUBZDQNSSJDN-UHFFFAOYSA-L
Meglumine metrizoateRJY6JR42WQ7241-11-4TXKOGNLDVKUFSI-WZTVWXICSA-N
Metrizoate magnesiumV717MS5D5B20968-37-0QGZYHVVYXBFUSE-UHFFFAOYSA-L
Metrizoate sodiumO65Q227UIC7225-61-8UKIYDXCFKFLIMU-UHFFFAOYSA-M

Categories

ATC Codes
V08AA02 — Metrizoic acid
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as acylaminobenzoic acid and derivatives. These are derivatives of amino benzoic acid derivatives where the amine group is N-acylated.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Acylaminobenzoic acid and derivatives
Alternative Parents
P-haloacetanilides / O-haloacetanilides / 2-halobenzoic acids / 4-halobenzoic acids / Halobenzoic acids / Benzoic acids / N-acetylarylamines / 1-carboxy-2-haloaromatic compounds / Benzoyl derivatives / Iodobenzenes
show 11 more
Substituents
1-carboxy-2-haloaromatic compound / 2-halobenzoic acid / 2-halobenzoic acid or derivatives / 4-halobenzoic acid / 4-halobenzoic acid or derivatives / Acetamide / Acetanilide / Acylaminobenzoic acid or derivatives / Anilide / Aromatic homomonocyclic compound
show 30 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
monocarboxylic acid (CHEBI:34847)
Affected organisms
Not Available

Chemical Identifiers

UNII
CM1N99QR1M
CAS number
1949-45-7
InChI Key
GGGDNPWHMNJRFN-UHFFFAOYSA-N
InChI
InChI=1S/C12H11I3N2O4/c1-4(18)16-10-7(13)6(12(20)21)8(14)11(9(10)15)17(3)5(2)19/h1-3H3,(H,16,18)(H,20,21)
IUPAC Name
3-acetamido-2,4,6-triiodo-5-(N-methylacetamido)benzoic acid
SMILES
CN(C(C)=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I

References

General References
  1. Nitter-Hauge S, Enge I: Metrizoic acid (Isopaque coronar) used in man for cardiac angiography. Radiology. 1976 Dec;121(3 Pt. 1):537-40. doi: 10.1148/121.3.537. [Article]
  2. Metrizoic Acid [Link]
  3. Metrizoic Acid [Link]
KEGG Compound
C14165
PubChem Compound
2528
PubChem Substance
310265220
ChemSpider
2433
ChEBI
34847
ChEMBL
CHEMBL1736
ZINC
ZINC000003831116
Wikipedia
Metrizoic_acid

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0877 mg/mLALOGPS
logP2.18ALOGPS
logP2.76Chemaxon
logS-3.8ALOGPS
pKa (Strongest Acidic)2.16Chemaxon
pKa (Strongest Basic)-3.9Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area86.71 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity106.24 m3·mol-1Chemaxon
Polarizability39.93 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000x-1000090000-768dbd3cc43adb825806
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-0000009000-64279d311891295ea64c
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-0000009000-6f9fed31a46547769571
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014r-0000090000-6cf2fbcf33ec592c1cdf
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-0200079000-1dd1f52ad53e5deff867
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-067i-0000390000-2b43844f8b88af8eedb9
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-6900000000-a622016dc2c45b042798
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-192.68877
predicted
DeepCCS 1.0 (2019)
[M+H]+195.23311
predicted
DeepCCS 1.0 (2019)
[M+Na]+202.64404
predicted
DeepCCS 1.0 (2019)

Drug created at November 27, 2015 21:08 / Updated at February 02, 2024 22:53